Space Asset Acquisition (NASDAQ:SAAQ) Upgraded at Wall Street Zen
by Doug Wharley · The Cerbat GemWall Street Zen upgraded shares of Space Asset Acquisition (NASDAQ:SAAQ – Free Report) to a hold rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings raised shares of Space Asset Acquisition from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, September 1st. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Space Asset Acquisition presently has a consensus rating of “Sell”.
Get Our Latest Research Report on Space Asset Acquisition
Space Asset Acquisition Stock Performance
Shares of NASDAQ SAAQ opened at $10.10 on Friday. Space Asset Acquisition has a twelve month low of $9.88 and a twelve month high of $11.10. The business has a 50 day simple moving average of $10.08 and a 200-day simple moving average of $10.17.
Institutional Investors Weigh In On Space Asset Acquisition
An institutional investor recently bought a new position in Space Asset Acquisition stock. Corient Private Wealth LP purchased a new stake in shares of Space Asset Acquisition Corp. (NASDAQ:SAAQ – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,000 shares of the company’s stock, valued at approximately $108,000.
Space Asset Acquisition Company Profile
Space Asset Acquisition Corp. is a special purpose acquisition company (SPAC) organized to identify and complete a business combination with one or more companies operating in the space industry. Unlike an operating company, it was formed primarily to raise capital and pursue a merger, acquisition, or similar transaction.
The company’s investment focus includes businesses involved in space-based technologies and services, such as satellite systems, space transportation, communications, data applications, and related infrastructure.
Further Reading
- Five stocks we like better than Space Asset Acquisition
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid